Tel Aviv / Zurich, 15 October 2018 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN)
(“SHL”), a leading provider and developer of advanced personal telemedicine solutions,
announced today that per the request of each of its three major shareholders: the Alroy Group
(holding 23.05% of the shares), Ms. Mengke Cai (holding 29.85%) and Ms. Kun Shen (holding
25.02%), SHL’s board of directors has resolved to postpone the Special General Meeting
Scheduled for October 18, 2018 to December 10, 2018.
For more information Click here